← 產業報告目錄
Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development And Biomarker Selection) And End Users (Pharmaceutical Companies, Biotechnology Companies), Region And Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-20頁數 179報告編號 INSIGHTACE-c5ddb06189
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 12.16 billion, the global Biomarker Discovery Outsourcing Services Market is anticipated to surge to USD 52.82 billion by 2031, demonstrating a CAGR of 20.38% during the 2024–2031 forecast window.
At its core, Biomarker Discovery Outsourcing Services pertains to key industry insights & findings from the report:
The market for biomarker discovery outsourcing services represents anticipated to be driven by a rise in the use of targeted medicines. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biomarker Discovery Outsourcing Services Market Snapshot
Chapter 4. Global Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Type:
5.2.1. Predictive biomarkers
5.2.2. Prognostic biomarkers
5.2.3. Safety biomarkers
5.2.4. Surrogate endpoints
Chapter 6. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Therapeutic Area:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Cardiology
6.2.4. Autoimmune Diseases
6.2.5. Others
Chapter 7. Market Segmentation 3: By Discovery Phase Estimates & Trend Analysis
7.1. By Discovery Phase & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Discovery Phase:
7.2.1. Biomarker Identification
7.2.2. Biomarker Validation
7.2.3. Biomarker Profiling
7.2.4. Biomarker Panel Development
7.2.5. Biomarker Selection
Chapter 8. Market Segmentation 4: By End-use Estimates & Trend Analysis
8.1. By End-use & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-use:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Others
Chapter 9. Biomarker Discovery Outsourcing Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By Type, 2024-2031
9.1.2. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2024-2031
9.1.3. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By Discovery Phase, 2024-2031
9.1.4. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By End-use, 2024-2031
9.1.5. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, 2024-2031
9.2.2. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, 2024-2031
9.2.3. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, 2024-2031
9.2.4. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, 2024-2031
9.2.5. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, 2024-2031
9.3.2. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, 2024-2031
9.3.3. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, 2024-2031
9.3.4. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, 2024-2031
9.3.5. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
9.4.2. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2024-2031
9.4.3. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, (US$ Million) 2024-2031
9.4.4. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, (US$ Million) 2024-2031
9.4.5. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
9.5.2. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2024-2031
9.5.3. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, (US$ Million) 2024-2031
9.5.4. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, (US$ Million) 2024-2031
9.5.5. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1 Laboratory Corporation of America Holdings
10.2.2 Charles River Laboratories
10.2.3 Eurofins Scientific
10.2.4 Celerion
10.2.5 ICON plc.
10.2.6 Parexel International (MA) Corporation
10.2.7 Proteome Sciences
10.2.8 GHO Capital
10.2.9 Thermo Fisher Scientific Inc.
10.2.10 Evotec.
10.2.11 Bio-Rad Laboratories, Inc.
10.2.12 Svar Life Science
10.2.13 Sino Biological, Inc
10.2.14 Almac Group Limited
10.2.15 REPROCELL Inc.
10.2.16 Frontage Labs
10.2.17 Biomcare ApS
10.2.18 Crown Bioscience
10.2.19 RayBiotech, Inc.
10.2.20 Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們